secwatch.observer — SEC 8-K summary
======================================

Issuer:     InfuSystem Holdings, Inc (INFU)
CIK:        0001337013
Form:       8-K
Filed at:   2026-08-04T10:31:28+00:00
Accession:  0001628280-26-052112
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InfuSystem Q2 net revenue $36.9M, up 2.6%; net income $3.2M; reaffirms 2026 guidance
--------------------------------------------------------------------------------

- Net revenues $36.9M (+2.6% YoY); Patient Services +15% to $24.8M, Device Solutions -16% to $12.1M.
- Net income $3.2M ($0.15 diluted EPS) vs $2.6M ($0.12) prior year; Adjusted EBITDA $8.6M (+7.6%), margin 23.4%.
- Reaffirmed FY 2026 guidance: pro-forma revenue growth 6-8%, Adjusted EBITDA margin mid-to-low 20s.
- Stock repurchases $3.5M in Q2; liquidity $55.2M as of June 30, 2026.
- GE Healthcare contract restructuring cut Device Solutions revenue $1.6M but improved profitability and margins.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1337013/000162828026052112/0001628280-26-052112-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1337013/000162828026052112/infu-20260804.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-052112

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer